Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 8,300 shares at $558.30 ($4.7M) on 2026-10-01, disclosed to the SEC on 2026-10-01.
Scheduled sale ($4.7M) by EVP & GENERAL COUNSEL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $558.30 | 880 | $491K | 10.5% |
| 2 | $560.19 | 1,480 | $829K | 17.7% |
| 3 | $561.87 | 780 | $438K | 9.3% |
| 4 | $563.09 | 1,480 | $833K | 17.8% |
| 5 | $566.41 | 400 | $227K | 4.8% |
| 6 | $567.76 | 720 |
| $409K |
| 8.7% |
| 7 | $569.15 | 739 | $421K | 9.0% |
| 8 | $570.90 | 838 | $478K | 10.2% |
| 9 | $572.25 | 823 | $471K | 10.0% |
| 10 | $573.15 | 160 | $92K | 2.0% |
| Total | $564.95 avg | 8,300 | $4.7M | 100% |
| Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-08-06 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-07-16 | $4.4M | — | Filing → |